Brazil's Hypermarcas sees steady demand growth through year-end

Reuters

SAO PAULO, Nov 4 (Reuters) - Hypermarcas SA,Brazil's biggest maker of generic drugs and personal careproducts, expects sales to increase in the fourth quarter from ayear earlier at the same pace seen so far in 2013, ChiefExecutive Officer Claudio Bergamo told analysts on a Mondayconference call.

On Saturday, Hypermarcas' third-quarter earnings beatanalysts' estimates after revenue rose faster than expenses. Netrevenue was up 12 percent on an annual basis because of productintroductions and marketing campaigns that will continue incoming quarters, Bergamo said.

View Comments (0)